Pfizer Inc. (BIT:1PFE)

Italy flag Italy · Delayed Price · Currency is EUR
20.06
-0.14 (-0.72%)
At close: May 9, 2025, 5:30 PM CET
-23.41%
Market Cap 112.43B
Revenue (ttm) 57.67B
Net Income (ttm) 7.28B
Shares Out n/a
EPS (ttm) 1.28
PE Ratio 15.45
Forward PE n/a
Dividend 1.57 (7.83%)
Ex-Dividend Date May 8, 2025
Volume 30,138
Average Volume 8,893
Open 20.29
Previous Close 20.20
Day's Range 19.82 - 20.29
52-Week Range 18.73 - 29.30
Beta n/a
RSI 38.57
Earnings Date Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Borsa Italiana
Ticker Symbol 1PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.